Share on StockTwits

Laboratory Corp. of America Holdings (NYSE:LH) issued its quarterly earnings data on Friday. The company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.07, Stock Ratings Network reports. The company had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.50 billion.

Shares of Laboratory Corp. of America Holdings (NYSE:LH) opened at 105.42 on Friday. Laboratory Corp. of America Holdings has a one year low of $87.01 and a one year high of $108.00. The stock’s 50-day moving average is $103.0 and its 200-day moving average is $97.51. The company has a market cap of $8.940 billion and a price-to-earnings ratio of 17.71.

LH has been the subject of a number of recent research reports. Analysts at William Blair upgraded shares of Laboratory Corp. of America Holdings from a “market perform” rating to an “outperform” rating in a research note on Thursday. On a related note, analysts at Maxim Group raised their price target on shares of Laboratory Corp. of America Holdings from $110.00 to $120.00 in a research note on Thursday. They now have a “buy” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Laboratory Corp. of America Holdings in a research note on Tuesday, May 20th. They now have a $105.00 price target on the stock. Ten investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $103.46.

Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.